PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Status:
Recruiting
Trial end date:
2024-07-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to construct a noninvasive approach using 68Ga- Mirc415 PET/CT
to detect the PD-L2 expression of tumor lesion in patients with colorectal cancer, lung
cancer and other solid tumor to identify patients benefiting from anti-PD-(L)1 treatment.